Open AccessHypoglycemia Associated with Antibiotics Alone and in Combination with Sulfonylureas and Meglitinides: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS)
Author(s) -
Kaitlin E. Kennedy,
Chengwen Teng,
Taylor M. Patek,
Christopher R. Frei
Publication year - 2019
Publication title -
drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.377
H-Index - 124
eISSN - 1179-1942
pISSN - 0114-5916
DOI - 10.1007/s40264-019-00901-7
Subject(s) - medicine , adverse event reporting system , tigecycline , ertapenem , hypoglycemia , moxifloxacin , adverse effect , linezolid , concomitant , odds ratio , antibiotics , pharmacology , vancomycin , microbiology and biotechnology , antibiotic resistance , insulin , imipenem , genetics , bacteria , biology , staphylococcus aureus
Fluoroquinolones, clarithromycin, linezolid, tigecycline, cefditoren, doxycycline, and trimethoprim-sulfamethoxazole are known to be associated with hypoglycemia, but few studies have considered concomitant glucose-lowering medications.